Quantcast

Posts related to ‘Pharmaceuticals’

Merck Close to 52-Week High After Earnings (MRK)

Posted: February 2, 2012 at 8:55 am

Merck & Company, Inc. (NYSE: MRK) is trading up after its earnings report.  With a high dividend yield of 4.4%, many investors are watching this despite a stance of little ...
Read Full Story »

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Posted: January 31, 2012 at 7:17 am

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company's guidance may be getting in the way a bit.  The ...
Read Full Story »

FTC Sues To Block Omnicare/PharMerica Merger; Express/Medco Next? (OCR, PMC, MHS, ESRX, T)

Posted: January 27, 2012 at 5:31 pm

The Federal Trade Commission is suing to block the merger between Omnicare, Inc. (NYSE: OCR) and Pharmerica Corporation (NYSE: PMC), where Omnicare is seeking to acquire the rival pharmacy provider PharMerica.... It ...
Read Full Story »

Risks Abound In Express Scripts & Medco Merger (MHS, ESRX, T, CHSI, MNA)

Posted: January 19, 2012 at 3:04 pm

The Medco Health Solutions Inc. (NYSE: MHS) and Express Scripts Inc. (NASDAQ: ESRX) merger saga is one which may go down in the financial history books for one of the ...
Read Full Story »

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

Posted: January 11, 2012 at 1:37 pm

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp ...
Read Full Story »

Short Sellers Help Push Dendreon Higher

Posted: January 6, 2012 at 6:39 am

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier ...
Read Full Story »

Morning Movers (MSHL, CSIQ, TRGT,PGNX, CIE)

Posted: December 20, 2011 at 10:20 am

There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share prices. These include Marshall Edwards Inc. (NASDAQ: MSHL), Canadian Solar ...
Read Full Story »

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Posted: December 8, 2011 at 11:14 am

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the ...
Read Full Story »

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

Posted: November 21, 2011 at 1:47 pm

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like ...
Read Full Story »

Dendreon Buyout, How Imminent?

Posted: November 17, 2011 at 1:45 pm

Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate – especially to a major pharmaceutical house seeking a unique ...
Read Full Story »

America’s Psychiatric Drug Addition

Posted: November 16, 2011 at 6:24 am

“Sell crazy someplace else; we’re all stocked up here,” says Jack Nicholson in 1997’s As Good as It Gets. There was a point, not so many years ago, when Prozac ...
Read Full Story »

The Eight Drug Shortages Putting Americans at Risk

Posted: November 5, 2011 at 11:07 am

President Obama this week signed an executive order directing federal regulators to address shortages of vital prescription drugs. According to the president, the order, which does not need congressional approval, ...
Read Full Story »

Economics of Painkiller Abuse

Posted: November 2, 2011 at 6:19 am

The regions of the U.S. in which painkiller use is extremely high also tend to be the poorest sections of the nation. Some of the reasons for this are not ...
Read Full Story »

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Posted: October 25, 2011 at 6:24 am

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring ...
Read Full Story »

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Posted: October 20, 2011 at 10:58 am

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will ...
Read Full Story »